510(k) K904416
K904416 is an FDA 510(k) premarket notification submitted by Biotrax, Inc. for the device "CROATEST (R) RHEUMATOID DIAGNOSTIC". The FDA issued a decision of Substantially Equivalent on June 24, 1991. The device falls under product code GTQ (Antistreptolysin - Titer/Streptolysin O Reagent), a Class I device regulated under 21 CFR 866.3720. Biotrax, Inc. has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 24, 1991
- Date Received
- September 27, 1990
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antistreptolysin - Titer/Streptolysin O Reagent
- Device Class
- Class I
- Regulation Number
- 866.3720
- Review Panel
- MI
- Submission Type